Banco Santander’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,730
Closed -$353K 417
2023
Q1
$353K Buy
+2,730
New +$357K 0.01% 325
2017
Q1
Sell
-42,132
Closed -$3.58M 145
2016
Q4
$3.58M Buy
+42,132
New +$3.83M 0.09% 57

Other funds holding IBB

Banco Santander's IBB Position: Q2 2023 in Review

Banco Santander sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 2,730 shares — an estimated $353K sold.

Banco Santander first reported a position in IBB in Q4 2016 and held it in 2 quarters. The position peaked at $3.58M in Q4 2016. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

  • Banco Santander reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
  • Banco Santander sold 2,730 iShares Biotechnology ETF shares in Q2 2023, an estimated $353K.
  • Banco Santander first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 2 quarters.
  • Banco Santander's iShares Biotechnology ETF position peaked at $3.58M in Q4 2016.
  • 843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Banco Santander's 13F filing for Q2 2023, filed 14 Aug 2023.